PharmaTher Holdings Ltd.
PHRRF
$0.179
$0.00734.25%
OTC PK
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -15.26% | -13.58% | -17.57% | -4.72% | 13.35% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -64.41% | -65.76% | -51.22% | -24.00% | -14.46% |
| Operating Income | 64.41% | 65.76% | 51.22% | 24.00% | 14.46% |
| Income Before Tax | 66.85% | 69.24% | 64.12% | 51.99% | 14.49% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 66.85% | 69.24% | 64.12% | 51.99% | 10.27% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 66.85% | 69.24% | 64.12% | 51.99% | 10.27% |
| EBIT | 64.41% | 65.76% | 51.22% | 24.00% | 14.46% |
| EBITDA | 64.41% | 65.75% | 51.21% | 23.99% | 14.45% |
| EPS Basic | 67.12% | 69.27% | 64.07% | 51.93% | 10.32% |
| Normalized Basic EPS | 63.54% | 65.40% | 50.00% | 22.39% | 15.79% |
| EPS Diluted | 67.12% | 69.27% | 64.07% | 51.93% | 10.32% |
| Normalized Diluted EPS | 63.54% | 65.40% | 50.00% | 22.39% | 15.79% |
| Average Basic Shares Outstanding | 0.36% | 0.26% | 0.16% | 0.07% | 0.02% |
| Average Diluted Shares Outstanding | 0.36% | 0.26% | 0.16% | 0.07% | 0.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |